Lesser doses for perioral treatment than for upper facial applications are utilised as the oral musculature responds more strongly to a similar BTX-A dosing. Only one preparing of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA approval lies in treatments of cervical dystonia. Additionally, there are https://jetonlinepharma.us/product-category/botulinum-toxins/